Active substance
Sodium lactate
- SFDA 3
- US FDA 5
- Safety 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| COMPOUND SODIUM LACTATE I.V INFUSION | 1.9 % | Solution · Intravenous use | 1 Bottle | SAR 4.95 | Generic · Prescription | GULF INJECT | Valid |
| HARTMANNS SOLUTION 1\2 | 1.9 % | Solution · Intravenous use | 1 Bottle | SAR 5.50 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| SODIUM LACTATE 1-6 MOLAR INFUSION | 18.5 g | Solution · Intravenous use | 1 Bag | SAR 9.05 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER | 1.87GM/100ML | injectable · injection | BAXTER HLTHCARE | Discontinued | 22 Mar 1971 |
| SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER | 1.87GM/100ML | injectable · injection | B BRAUN | Discontinued | 15 Jun 1979 |
| SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER | 1.87GM/100ML | injectable · injection | HOSPIRA | Discontinued | 25 Jul 1980 |
| SODIUM LACTATE IN PLASTIC CONTAINER | 5MEQ/ML | injectable · injection | HOSPIRA | Discontinued | 5 Sep 1984 |
| SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER | 1.87GM/100ML | injectable · injection | B BRAUN | Discontinued | 21 Apr 1992 |
Safety signals and safety-related labeling changes
- US FDA 5 Nov 2025 LACTATED RINGER'S IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions - US FDA 5 Nov 2025 LACTATED RINGER'S IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions
Combinations containing Sodium lactate
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.